参考文献/References:
[1] Lee JW, Park JA, Lee YJ, et al.New glucocyclic RGD dimers for positron emission tomography imaging of tumor integrin receptors[J].Cancer Biother Radiopharm, 2016, 31(6):209-216.DOI:10.1089/cbr.2016.2015.
[2] Kim YI, Yoon HJ, Paeng JC, et al.Prognostic value of 68Ga-NOTA-RGD PET/CT for predicting disease-free survival for patients with breast cancer undergoing neoadjuvant chemotherapy and surgery:a comparison study with dynamic contrast enhanced MRI[J].Clin Nucl Med, 2016, 41(8):614-620.DOI:10.1097/RLU.0000000000001274.
[3] Takahashi S, Leiss M, Moser M, et al.The RGD motif in fibronectin is essential for development but dispensable for fibril assembly[J].J Cell Biol, 2007, 178(1):167-178.DOI:10.1083/jcb.200703021.
[4] Curnis F, Sacchi A, Gasparri A, et al.Isoaspartate-glycine-arginine:a new tumor vasculature-targeting motif[J].Cancer Res, 2008, 68(17):7073-7082.DOI:10.1158/0008-5472.CAN-08-1272.
[5] 洪愉, 曾韦锟, 赵明玄, 等.靶向整合素αvβ3受体isoDGR-2CY的131I标记与生物活性评价[J].西南国防医药, 2013, 23(10):1048-1051.DOI:10.3969/j.issn.1004-0188.2013.10.002.Hong Y, Zeng WK, Zhao MX, et al.131I labeling and bioactivity evaluation for receptor isoDGR-CY of targeting integrin αvβ3[J].Med J Nat Defen Force SW Chin, 2013, 23(10):1048-1051.
[6] Lahorte CM, Vanderheyden JL, Steinmetz N, et al.Apoptosis-detecting radioligands:current state of the art and future perspectives[J].Eur J Nucl Med Mol Imaging, 2004, 31(6):887-919.DOI:10.1007/s00259-004-1555-4.
[7] 张迎强, 蔡炯, 李方, 等.荷肉瘤小鼠肿瘤细胞凋亡显像实验研究[J].医学研究杂志, 2007, 36(2):30-33.DOI:10.3969/j.issn.1673-548X.2007.02.011.Zhang YQ, Cai J, Li F, et al.The experimental study on apoptosis imaging in sarcoma-grafted mice[J].J Med Res, 2007, 36(2):30-33.
[8] Tesic M, Sheldon KM, Ballinger JR, et al.Labelling small quantities of monoclonal antibodies and their F(ab’)2 fragments with technetium-99m[J].Nucl Med Biol, 1995, 22(4):451-457.DOI:10.1016/0969-8051(94)00132-4.
[9] Ruan C, Wang Q, He G, et al.Radioimmunoimaging of arterial and venous thrombi in canine model using 99mTc labeled monoclonal antifibrin antibody[J].Chin Med J(Engl), 1997, 110(1):69-72.
[10] 季顺东, 方纬, 范磊, 等.99Tcm标记人源化抗人血小板膜糖蛋白Ⅲa单克隆抗体SZ21F(ab)2血栓栓塞显像[J].中华核医学杂志, 2007, 27(3):173-176.DOI:10.3760/cma.j.issn.2095-2848.2007.03.013.Ji SD, Fang W, Fan L, et al.Imaging of thromboembolism with 99Tcm-SZ21F(ab)2, a humanized anti-platelet glycoprotein Ⅲa monoclonal antibody F(ab)2 fragment[J].Chin J Nucl Med, 2007, 27(3):173-176.
相似文献/References:
[1]张晓,兰晓莉,胡帆,等.点击化学在分子影像学中的应用和进展[J].国际放射医学核医学杂志,2016,40(3):196.[doi:10.3760/cma.j.issn.1673-4114.2016.03.008]
Zhang Xiao,Lan Xiaoli,Hu Fan,et al.Applications and advances of click chemistry in molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):196.[doi:10.3760/cma.j.issn.1673-4114.2016.03.008]
[2]汪文霞,兰晓莉,张永学.HER2的表达及其分子影像的研究进展[J].国际放射医学核医学杂志,2016,40(5):363.[doi:10.3760/cma.j.issn.1673-4114.2016.05.007]
Wang Wenxia,Lan Xiaoli,Zhang Yongxue.Research and development of HER2 expression molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):363.[doi:10.3760/cma.j.issn.1673-4114.2016.05.007]
[3]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[4]李帅,李剑明.动脉粥样硬化易损斑块放射性核素标记分子探针的研究进展[J].国际放射医学核医学杂志,2015,39(1):80.[doi:10.3760/cma.j.issn.1673-4114.2015.01.017]
Li Shuai,Li Jianming.Research progress of molecular probes labeled with radionuclide for imaging of atherosclerosis vulnerable plaque[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):80.[doi:10.3760/cma.j.issn.1673-4114.2015.01.017]
[5]林潇,唐明灯.靶向表皮生长因子受体分子探针研究进展[J].国际放射医学核医学杂志,2015,39(1):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
Lin Xiao,Tang Mingdeng.Research progresses on molecular probes targeting epidermal growth factor receptor[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
[6]孔艳艳,管一晖,吴平.PET分子探针在阿尔茨海默病早期诊断中的研究进展[J].国际放射医学核医学杂志,2012,36(5):257.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.001]
KONG Yan-yan,GUAN Yi-hui,WU Ping.Novel PET molecular probes for early diagnosis of Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):257.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.001]
[7]夏伟,吕中伟,王国玉,等.99Tcm标记depreotide及与肺腺癌A549细胞亲和性研究[J].国际放射医学核医学杂志,2010,34(4):193.[doi:10.3760/cma.j.issn.1673-4114.2010.04.001]
XIA Wei,LÜ,Zhong-wei,et al.Experimental studies of depreotide labeled with 99Tcm and the affinity with human lung adenocarcinoma cell line A549[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):193.[doi:10.3760/cma.j.issn.1673-4114.2010.04.001]
[8]吴涛,安锐.分子影像报告基因系统的研究进展[J].国际放射医学核医学杂志,2010,34(4):198.[doi:10.3760/cma.j.issn.1673-4114.2010.04.002]
WU Tao,AN Rui.Advances in study of molecular imaging reporter gene systems[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(5):198.[doi:10.3760/cma.j.issn.1673-4114.2010.04.002]
[9]陈铨,张永学.分子成像技术的研究进展[J].国际放射医学核医学杂志,2011,35(5):290.[doi:10.3760/cma.j.issn.1673-4114.2011.05.010]
CHEN Quan,ZHANG Yong-xue.Progress on molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):290.[doi:10.3760/cma.j.issn.1673-4114.2011.05.010]
[10]朱沭,赵明,陈璟.核酸及其类似物的常见放射性核素标记及显像[J].国际放射医学核医学杂志,2011,35(1):44.[doi:10.3760/cma.j.issn.1673-4114.2011.01.013]
ZHU Shu,ZHAO Ming,CHEN Jing.Radionuclide labeling and imaging nucleic acids and its analogues[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):44.[doi:10.3760/cma.j.issn.1673-4114.2011.01.013]